Meningococcal vaccines routinely used in the United States protect against most types of meningococcal disease, but they do not prevent all cases. There are two kinds of vaccines against Neisseria meningitidis bacteria available in the United States: meningococcal polysaccharide vaccine (Menomune®) and meningococcal conjugate vaccine (Menactra®, Menveo® and MenHibrix®).
For more information on meningococcal vaccines and who should receive them, visit the Meningococcal Vaccine site or Recommendations of the Advisory Committee on Immunization Practices.
- Meningococcal Vaccine Basics
Offers comprehensive information about meningococcal vaccines and other educational tools.
- Who Should Get the Vaccine
- Who Should Not Get the Vaccine
- Possible Reactions to Vaccination
- Vaccine Safety
Meningococcal Vaccine Resources for Health Care Professionals
- Meningococcal Vaccination
- Interim Guidance for Control of Serogroup B Meningococcal Disease Outbreaks in Organizational Settings [6 pages]
- Provider Education
The National Immunization Survey (NIS) is a large, on-going survey of immunization coverage among US pre-school children (19-35 months of age). In conjunction with the NIS, CDC also conducts the NIS-Teen (13 to 17 years of age) and the NIS-Adult.
- Page last reviewed: April 1, 2014
- Page last updated: November 28, 2014
- Content source:
- Content source: National Center for Immunization and Respiratory Diseases